Zacks Investment Research cut shares of LHC Group (NASDAQ:LHCG) from a buy rating to a hold rating in a research report sent to investors on Thursday morning.

According to Zacks, “LHC Group provides post-acute healthcare services primarily to Medicare beneficiaries in rural markets in the southern United States. They provide home-based services through their home nursing agencies and hospices and facility-based services through their long-term acute care hospitals and outpatient rehabilitation clinics. “

LHCG has been the subject of a number of other reports. Royal Bank Of Canada restated a buy rating and issued a $69.00 price target on shares of LHC Group in a research report on Friday, May 5th. Benchmark Co. upped their price target on LHC Group from $63.00 to $72.00 and gave the company a buy rating in a research report on Thursday, June 8th. Jefferies Group LLC restated a buy rating and issued a $65.00 price target (up from $56.00) on shares of LHC Group in a research report on Friday, May 5th. Stephens set a $69.00 price target on LHC Group and gave the company a buy rating in a research report on Saturday, May 6th. Finally, SunTrust Banks, Inc. upgraded LHC Group from a hold rating to a buy rating and upped their price target for the company from $50.00 to $56.00 in a research report on Friday, March 10th. One analyst has rated the stock with a hold rating and seven have given a buy rating to the company. The stock has an average rating of Buy and a consensus price target of $64.38.

Shares of LHC Group (LHCG) traded up 1.06% during trading on Thursday, hitting $65.50. The stock had a trading volume of 6,464 shares. The firm has a market cap of $1.20 billion, a price-to-earnings ratio of 30.32 and a beta of 0.80. The firm’s 50-day moving average is $63.33 and its 200 day moving average is $53.11. LHC Group has a 52-week low of $32.04 and a 52-week high of $69.35.

COPYRIGHT VIOLATION WARNING: This story was originally posted by Daily Political and is owned by of Daily Political. If you are viewing this story on another domain, it was stolen and republished in violation of US and international trademark and copyright law. The original version of this story can be accessed at https://www.dailypolitical.com/2017/07/12/lhc-group-lhcg-stock-rating-lowered-by-zacks-investment-research.html.

In related news, Director Coliseum Capital Management, L sold 8,632 shares of the stock in a transaction that occurred on Friday, May 19th. The stock was sold at an average price of $60.25, for a total value of $520,078.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, COO Donald Dwayne Stelly sold 3,181 shares of the stock in a transaction that occurred on Thursday, June 8th. The stock was sold at an average price of $64.97, for a total value of $206,669.57. Following the completion of the transaction, the chief operating officer now owns 114,235 shares of the company’s stock, valued at $7,421,847.95. The disclosure for this sale can be found here. Insiders sold 682,839 shares of company stock valued at $42,140,531 over the last quarter. 14.80% of the stock is currently owned by company insiders.

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Capstone Asset Management Co. acquired a new position in shares of LHC Group during the second quarter valued at $245,000. Point72 Asset Management L.P. raised its position in LHC Group by 292.3% in the first quarter. Point72 Asset Management L.P. now owns 439,399 shares of the health services provider’s stock valued at $23,684,000 after buying an additional 327,399 shares in the last quarter. Iguana Healthcare Management LLC raised its position in LHC Group by 16.7% in the first quarter. Iguana Healthcare Management LLC now owns 35,000 shares of the health services provider’s stock valued at $1,887,000 after buying an additional 5,000 shares in the last quarter. State Street Corp raised its position in LHC Group by 4.7% in the first quarter. State Street Corp now owns 391,375 shares of the health services provider’s stock valued at $21,095,000 after buying an additional 17,439 shares in the last quarter. Finally, Bank of America Corp DE raised its position in LHC Group by 123.5% in the first quarter. Bank of America Corp DE now owns 34,658 shares of the health services provider’s stock valued at $1,868,000 after buying an additional 19,154 shares in the last quarter. Institutional investors own 84.75% of the company’s stock.

LHC Group Company Profile

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Get a free copy of the Zacks research report on LHC Group (LHCG)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.